A rare case of visceral leishmaniasis in an immunocompetent traveler returning to the United States from Europe.
Lamia Y HaqueMerceditas VillanuevaArmand RussoYouzhong YuanEun-Ju LeeJeffrey E TopalNikolai PodoltsevPublished in: PLoS neglected tropical diseases (2018)
A young, healthy traveler returning to the United States presented with fever, night sweats, splenomegaly, and pancytopenia. Bone marrow biopsy revealed leishmaniasis (Leishmania infantum), likely acquired in southern France. Although many cases of endemic visceral leishmaniasis (VL) have been reported in Europe, this is a rare case of imported VL in a healthy traveler returning from Europe to the US. Despite successful initial treatment with liposomal amphotericin B (LamB), relapse occurred. Treatments for VL in immunocompetent individuals are highly effective, but relapse can occur. There is more extensive experience in endemic areas with treating relapse that may be lacking in North America. This case alerts physicians in the US that immunocompetent adults can acquire VL during brief visits to endemic areas in Europe. It is important that travelers be counseled on preventive measures. Patients should be monitored after treatment for relapse.
Keyphrases
- rare case
- free survival
- bone marrow
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- primary care
- mesenchymal stem cells
- peritoneal dialysis
- prognostic factors
- ultrasound guided
- physical activity
- patient reported outcomes
- fine needle aspiration
- combination therapy
- depressive symptoms
- patient reported
- replacement therapy
- smoking cessation